
Gonzalo Herranz Gómez holds a BSc in Biology from the Autonomous University of Madrid (UAM) and an MSc in Biochemistry, Molecular Biology and Biomedicine from the Complutense University of Madrid (UCM). He obtained his PhD at the Centro de Biología Molecular Severo Ochoa (CBM, CSIC-UAM), where he investigated the physiological and metabolic properties of neonatal enterocytes and uncovered a key role for mitophagy in maintaining their function. During his doctoral training, he completed a research stay at the Institute for Bioengineering of Catalonia (IBEC) in Barcelona, where he gained expertise in 2D and 3D intestinal organoid models. He is currently a postdoctoral researcher in the Balsa Lab, where his research focuses on how mitochondrial quality control and metabolic plasticity influence cancer progression. In particular, he investigates the role of mitophagy in breast cancer dormancy and the metabolic adaptations that enable melanoma cells to disseminate and colonize distant organs.









